Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.

为低鼠抗引起的超敏反应,疗性单克隆抗已由改型抗,化抗发展到全抗。